Rockefeller Capital Management L.P. Has $274,000 Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Rockefeller Capital Management L.P. reduced its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 9.6% during the third quarter, HoldingsChannel reports. The firm owned 10,711 shares of the company’s stock after selling 1,139 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in ARK Genomic Revolution ETF were worth $274,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ARKG. Main Management ETF Advisors LLC lifted its stake in ARK Genomic Revolution ETF by 2.3% in the 2nd quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock valued at $64,678,000 after purchasing an additional 62,470 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of ARK Genomic Revolution ETF by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after acquiring an additional 3,341 shares during the last quarter. Prudential PLC boosted its holdings in shares of ARK Genomic Revolution ETF by 15.0% during the 2nd quarter. Prudential PLC now owns 140,170 shares of the company’s stock valued at $3,326,000 after acquiring an additional 18,300 shares in the last quarter. SG Americas Securities LLC grew its position in ARK Genomic Revolution ETF by 5.4% during the 2nd quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock worth $3,037,000 after acquiring an additional 6,675 shares during the last quarter. Finally, Bellecapital International Ltd. increased its holdings in ARK Genomic Revolution ETF by 15.6% in the 2nd quarter. Bellecapital International Ltd. now owns 74,833 shares of the company’s stock worth $1,757,000 after purchasing an additional 10,100 shares in the last quarter.

ARK Genomic Revolution ETF Stock Up 0.5 %

ARK Genomic Revolution ETF stock opened at $26.54 on Wednesday. The company has a 50 day moving average price of $24.71 and a 200-day moving average price of $25.10.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.